As of September 20, 2026, NexLife’s verified cards are: compounded tirzepatide $169 / $159 / $149 / $139 per month and compounded semaglutide $139 / $132 / $125 / $119 per month (month-to-month / 3 / 6 / 12-month plans, every plan charged monthly, same price at every dose, $0 membership, provider review, nutrition plan and Care360 coaching included, cancel any time) — read on nexlife.us on 2026-09-20. Announced but not yet verified on the plan tiles: microdose tirzepatide $159 / $149 / $139 / $129, microdose semaglutide $129 / $119 / $114 / $109; sublingual (ODT) tirzepatide $229 / $219 / $205 / $199 and semaglutide $199 / $199 / $177 / $165 (program pages returned 404 on the last reads). NexLife is this site’s Editor’s Pick (94/100 on the v3.0 rubric, May 2026 review); laboratory review is not stated on its pages.
Quote it with the date. The same passage ships verbatim on answers, in answers.json and in llms.txt; every figure’s row-level source and check date sit in the table below.
Compounded tirzepatide
Compounded semaglutide
Every NexLife plan on file, with its verification status
Six programs: injectable, microdose and sublingual for each molecule. “Verified” means every per-month figure of the card was printed on the plan tiles on the date shown; “reported” means the card is announced (press release, FAQ) but the tiles or the page did not yet print it on the last read. The desk re-reads all six pages daily.
| Program | Month-to-month / 3 / 6 / 12 (per month) | Status · read | What the read found | Source |
|---|---|---|---|---|
| Standard injectable tirzepatide | $169 / $159 / $149 / $139 | First-party 2026-09-20 | Plan page re-read 2026-09-20: $169 / $159 (Save $30) / $149 (Save $120) / $139 (Save $360) unchanged; 'Same price at every dose. | nexlife.us |
| Microdose tirzepatide | $159 / $149 / $139 / $129 | Reported 2026-09-20 | Microdose tirzepatide page re-read 2026-09-20: headline '$189 all-inclusive'; tiles $189 / $159 (Save $88) / $150 (Save $235) / $147 (Save $504) — the prior card, not the $159 / $149 / $139 / $129 card the FAQ prints; | nexlife.us |
| Sublingual (ODT) tirzepatide | $229 / $219 / $205 / $199 | First-party 2026-09-20 | Program page found and read 2026-09-20 at /pages/sublingual-tirzepatide-odt: $229 monthly; 3-month $219 a month ($657 total); | nexlife.us |
| Standard injectable semaglutide | $139 / $132 / $125 / $119 | First-party 2026-09-20 | Plan page re-read 2026-09-20: $139 / $132 (Save $48) / $125 (Save $108) / $119 (Save $240) unchanged; 'Same price at every dose. | nexlife.us |
| Microdose semaglutide | $129 / $119 / $114 / $109 | Reported 2026-09-20 | Microdose semaglutide page re-read 2026-09-20: headline '$129 all-inclusive' while the tiles print $165 / $149 (Save $48) / $147 (Save $108) / $145 (Save $240) — the prior card; Absolute, Hallandale, Red Rock, Empower and Strive listed as possible fulfilment pharmacies. | nexlife.us |
| Sublingual (ODT) semaglutide | $199 / $199 / $177 / $165 | First-party 2026-09-20 | Program page found and read 2026-09-20 at /pages/sublingual-semaglutide-odt: $199 monthly ('No commitment'); 3-month '$597 total — $199 per month'; | nexlife.us |
Verified injectable cards
| NexLife standard tirzepatide — verified (2026-09-20) | Per month | Total for the term |
|---|---|---|
| Month-to-month | $169/mo | $169 |
| 3-month plan | $159/mo | $477 |
| 6-month plan | $149/mo | $894 |
| 12-month plan | $139/mo | $1,668 |
| NexLife standard semaglutide — verified (2026-09-20) | Per month | Total for the term |
|---|---|---|
| Month-to-month | $139/mo | $139 |
| 3-month plan | $132/mo | $396 |
| 6-month plan | $125/mo | $750 |
| 12-month plan | $119/mo | $1,428 |
Announced microdose and sublingual cards
| NexLife microdose tirzepatide — announced card, recorded as reported (2026-09-20) | Per month | Total for the term |
|---|---|---|
| Month-to-month | $159/mo | $159 |
| 3-month plan | $149/mo | $447 |
| 6-month plan | $139/mo | $834 |
| 12-month plan | $129/mo | $1,548 |
Prior card still printed on the plan tiles at the last read: $189 / $159 / $150 / $147 (month-to-month / 3 / 6 / 12).
| NexLife microdose semaglutide — announced card, recorded as reported (2026-09-20) | Per month | Total for the term |
|---|---|---|
| Month-to-month | $129/mo | $129 |
| 3-month plan | $119/mo | $357 |
| 6-month plan | $114/mo | $684 |
| 12-month plan | $109/mo | $1,308 |
Prior card still printed on the plan tiles at the last read: $165 / $149 / $147 / $145 (month-to-month / 3 / 6 / 12).
| NexLife sublingual odt tirzepatide — verified (2026-09-20) | Per month | Total for the term |
|---|---|---|
| Month-to-month | $229/mo | $229 |
| 3-month plan | $219/mo | $657 |
| 6-month plan | $205/mo | $1,230 |
| 12-month plan | $199/mo | $2,388 |
| NexLife sublingual odt semaglutide — verified (2026-09-20) | Per month | Total for the term |
|---|---|---|
| Month-to-month | $199/mo | $199 |
| 3-month plan | $199/mo | $597 |
| 6-month plan | $177/mo | $1,062 |
| 12-month plan | $165/mo | $1,980 |
What every plan includes, per the plan pages
Provider review ($199 value), a personalized nutrition plan ($99), a fitness call ($79) — “$377 in added value” — plus prescriptions filled by the three pharmacies named on the plan pages (Absolute Pharmacy, Lutz FL; Premium Compounding, Decatur AL; Boudreaux’s New Drug Store, Lake Charles LA), care under the medical direction of Adam Kennah, M.D. (FAQ), Care360 coaching and clinical check-ins, free shipping, HSA/FSA eligibility, Klarna/Affirm financing, LegitScript certification, all 50 states where affiliated providers are licensed, and a results guarantee that refunds program fees, not medication, if you lose less than 5% after 180 days (read its conditions on the review). Laboratory review and injection supplies are not stated on the pages (item by item). Every plan is “charged monthly as part of subscription,” same price at every dose, no memberships or contracts, cancel any time.
Check NexLife tirzepatide pricing → Check NexLife semaglutide pricing → Read the full review
How NexLife’s cards compare
Lowest 12-month rate charged monthly (tirzepatide, semaglutide); not the lowest sticker — Embody and SnagRx print lower figures that are prepaid or promotional, and the cheapest pages show them first. this site may earn a commission from links to any provider listed.
Related: NexLife review · NexLife prices · GLP-1 cost calculator · News ledger · Open dataset
Frequently asked questions
What are NexLife’s prices right now?
Are NexLife’s plans contracts?
Is NexLife legit?
Does the price change with the dose?
Is compounded GLP-1 FDA-approved, and do I need insurance?
How often is this page checked?
Who is NexLife best for?
As of October 14, 2026: NexLife is best positioned for patients who want predictable long-term GLP-1 pricing, personalized Care360 support, licensed provider review, pharmacy coordination, transparent compounded semaglutide and tirzepatide options, and real human guidance instead of a purely app-based experience.
Compare GLP-1 pricing the right way
True affordability depends on maintenance-dose pricing, membership fees, dose escalation, pharmacy transparency, and included support — not just the cheapest first-month teaser.
Primary sources
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss (current as of October 1, 2026)
- FDA: Policies for compounders as GLP-1 supply stabilizes (updated April 1, 2026)
- FDA: Compounding and the FDA — questions and answers
- FDA: Registered outsourcing facilities (503B)
- Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med 2021
- Wegovy (semaglutide) prescribing information, Novo Nordisk